Skip to main content
. 2016 Mar 8;11(2):177–183. doi: 10.1177/1558944715627618

Table 1.

Summary of AEs.

Lidocaine (n = 53)
Marcaine (n = 50)
Exparel (n = 51)
Total (n = 154)
n (%) n (%) n (%) n (%)
Patients with one or more AE 7 (13.2) 5 (10) 2 (3.9) 14 (9.1)
Dry mouth 4 (7.5) 2 (4.0) 0 (0) 6 (3.9)
Nausea 5 (9.4) 0 (0) 1 (2.0) 6 (3.9)
Vomiting 3 (5.7) 0 (0) 1 (2.0) 4 (2.6)
Feeling drowsy 2 (3.8) 2 (4.0) 0 (0) 4 (2.6)
Trouble sleeping 2 (3.8) 0 (0) 0 (0) 2 (1.3)
Feeling bloated 1 (1.9) 0 (0) 0 (0) 1 (0.6)
Constipation 1 (1.9) 1 (2.0) 0 (0) 2 (1.3)
Trouble urinating 1 (1.9) 1 (2.0) 0 (0) 2 (1.3)
Itching 3 (5.7) 3 (6.0) 0 (0) 6 (3.9)
Dizziness 1 (1.9) 0 (0) 0 (0) 1 (0.6)
Sweating 0 (0) 2 (4.0) 0 (0) 2 (1.3)
Coughing 0 (0) 0 (0) 1 (2.0) 1 (0.6)
Lack of energy 4 (7.5) 1 (2.0) 1 (2.0) 6 (3.9)

Note. AEs, adverse events.